4D Molecular Therapeutics | Sustainability Performance
Develops gene therapies for ophthalmic and pulmonary diseases using engineered vectors.
2013
United States
201 - 500 employees
Biotechnology
$25M - 100M in revenue
Sustainability Ranking & Industry Benchmark
#7377
Overall#1565
in United States#150
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Reporting
Not reporting on Sustainability
Not committed to key sustainability initiatives